Detalhe da pesquisa
1.
Vaccine protection against Zika virus from Brazil.
Nature
; 536(7617): 474-8, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355570
2.
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
J Virol
; 92(13)2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643249
3.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Cell Host Microbe
; 25(1): 59-72.e8, 2019 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30629920
4.
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
PLoS One
; 13(11): e0205139, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427829
5.
Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy.
Open Forum Infect Dis
; 3(2): ofw100, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27419172
6.
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.
Science
; 353(6304): 1129-32, 2016 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492477
7.
Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.
J Immunol Methods
; 416: 105-23, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445329
8.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Cell Host Microbe
; 26(2): 296, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31415756